BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33166788)

  • 1. High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients.
    Yeregui E; Viladés C; Domingo P; Ceausu A; Pacheco YM; Veloso S; Inciarte A; Vidal-González J; Peraire M; Perpiñán C; Falcó V; Masip J; Alba V; Vargas M; Martí A; Reverté L; Mallolas J; Vidal F; Peraire J; Rull A
    EBioMedicine; 2020 Dec; 62():103077. PubMed ID: 33166788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
    Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
    Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Better CD4+ T cell recovery in Brazilian HIV-infected individuals under HAART due to cumulative carriage of SDF-1-3'A, CCR2-V64I, CCR5-D32 and CCR5-promoter 59029A/G polymorphisms.
    Rigato PO; Hong MA; Casseb J; Ueda M; de Castro I; Benard G; Duarte AJ
    Curr HIV Res; 2008 Sep; 6(5):466-73. PubMed ID: 18855658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
    Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
    Gene; 2020 May; 741():144568. PubMed ID: 32165289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression.
    Restrepo C; Gutierrez-Rivas M; Pacheco YM; García M; Blanco J; Medrano LM; Navarrete-Muñoz MA; Gutiérrez F; Miralles P; Dalmau D; Gómez JL; Górgolas M; Cabello A; Resino S; Benito JM; Rallón N;
    PLoS One; 2019; 14(3):e0214421. PubMed ID: 30921390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.
    O'Brien TR; McDermott DH; Ioannidis JP; Carrington M; Murphy PM; Havlir DV; Richman DD
    AIDS; 2000 May; 14(7):821-6. PubMed ID: 10839590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of chemokines and their receptors genes polymorphisms with risk of myocardial infarction].
    Xu X; Wang LH; Liu HB; Xu CF; Zhang P; Yong F; Shi YP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):601-7. PubMed ID: 24078580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.
    Nahon P; Sutton A; Rufat P; Simon C; Trinchet JC; Gattegno L; Beaugrand M; Charnaux N
    World J Gastroenterol; 2008 Feb; 14(5):713-9. PubMed ID: 18205260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.
    Puissant B; Roubinet F; Massip P; Sandres-Saune K; Apoil PA; Abbal M; Pasquier C; Izopet J; Blancher A
    AIDS Res Hum Retroviruses; 2006 Feb; 22(2):153-62. PubMed ID: 16478397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
    Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
    HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR2, CCR5, and CXCL12 variation and HIV/AIDS in Papua New Guinea.
    Mehlotra RK; Hall NB; Bruse SE; John B; Zikursh MJB; Stein CM; Siba PM; Zimmerman PA
    Infect Genet Evol; 2015 Dec; 36():165-173. PubMed ID: 26397046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India.
    Ramana GV; Vasanthi A; Khaja M; Su B; Govindaiah V; Jin L; Singh L; Chakraborty R
    J Genet; 2001 Dec; 80(3):137-40. PubMed ID: 11988632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.
    Szalai C; Duba J; Prohászka Z; Kalina A ; Szabó T; Nagy B; Horváth L; Császár A
    Atherosclerosis; 2001 Sep; 158(1):233-9. PubMed ID: 11500196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.
    Geskus RB; Meyer L; Hubert JB; Schuitemaker H; Berkhout B; Rouzioux C; Theodorou ID; Delfraissy JF; Prins M; Coutinho RA
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):321-6. PubMed ID: 15980693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of CCR-5Δ32, CCR2-64I, and SDF-1-3'A alleles among Jordanians.
    Khabour OF; Abu-Haweleh LJ; Alzoubi KH
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):151-5. PubMed ID: 22770415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.